Tessellate BIO
PrivateLast Round
Seed
Oct 17, 2023
Total Funding Raised
$8.4M
Company Overview
Tessellate BIO operates in Healthcare & Life Sciences and is based in Naarden. Its latest recorded funding round was a Seed round in October 2023.
Tessellate BIO is a biotechnology company that discovers and develops novel precision oncology medicines with a focus on synthetic lethality.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tessellate BIO Comparables
Compare Tessellate BIO with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ALTx Therapeutics | 88% | |
| Breakpoint Therapeutics | 80% | |
| Nodus Oncology | 79% |
For institutional investors. Book with your work email.
Tessellate BIO Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Tessellate BIO Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Forbion | Seed |
| BioGeneration Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 8, 2025
Monthly visitors grew 84% MoM, reaching 1.3K.
- May 2, 2025
Monthly visitors grew 160% MoM, reaching 2.6K.
For institutional investors. Book with your work email.
Tessellate BIO Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Tessellate BIO's valuation, stock price, and market status.
Is Tessellate BIO a public or private company?
Tessellate BIO is a private company.
What is the current stock price of Tessellate BIO?
Tessellate BIO is a private company, so its shares have no public market price. Caplight tracks Tessellate BIO's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Tessellate BIO worth (valuation)?
Valuation information for Tessellate BIO is not publicly available.
Can I buy Tessellate BIO stock?
Tessellate BIO shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Tessellate BIO's last funding round?
Tessellate BIO's most recent funding round was Seed on October 17, 2023.
Who are the main investors in Tessellate BIO?
Key investors in Tessellate BIO include Forbion, BioGeneration Ventures.
Will Tessellate BIO IPO soon?
No public IPO plans have been announced for Tessellate BIO.
How can I track Tessellate BIO secondary market activity?
Caplight tracks bids, offers, and trades in Tessellate BIO's shares on secondary markets.